These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16382056)

  • 21. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 22. What you need to know about Medicare Part D.
    Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
    [No Abstract]   [Full Text] [Related]  

  • 23. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceuticals: Medicare Modernization Act.
    Hilyard K; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-28. PubMed ID: 17361467
    [No Abstract]   [Full Text] [Related]  

  • 27. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D; Schwarz M
    Inquiry; 2007; 44(2):157-66. PubMed ID: 17850042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare's outpatient prescription drug benefit.
    Dillingham GL; Solomon JH
    Pride Inst J Long Term Home Health Care; 1989; 8(1):3-14. PubMed ID: 10303361
    [No Abstract]   [Full Text] [Related]  

  • 29. Should Medicare adopt the Veterans Health Administration formulary?
    Frakt AB; Pizer SD; Feldman R
    Health Econ; 2012 May; 21(5):485-95. PubMed ID: 21506191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 32. PBMs and a Medicare prescription drug benefit.
    Cohen JP
    Food Drug Law J; 2000; 55(3):311-20. PubMed ID: 11824463
    [No Abstract]   [Full Text] [Related]  

  • 33. What a Food and Drug lawyer should know about the Medicare Modernization Act.
    Azar AM
    Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 35. Part I--Medicare prescription drug coverage (Part D): the promise.
    Witten B
    Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
    [No Abstract]   [Full Text] [Related]  

  • 36. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 37. Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D.
    Duggan M; Healy P; Morton FS
    J Econ Perspect; 2008; 22(4):69-92. PubMed ID: 19768843
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicare prescription drug plans: the impact on physician practice.
    Marable S
    Med Health R I; 2006 Jan; 89(1):39-40. PubMed ID: 16519205
    [No Abstract]   [Full Text] [Related]  

  • 39. The new Medicare prescription drug benefit: important issues for physician practices.
    Falk R; Stranne S
    J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inadequate prescription-drug coverage for Medicare enrollees--a call to action.
    Soumerai SB; Ross-Degnan D
    N Engl J Med; 1999 Mar; 340(9):722-8. PubMed ID: 10053183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.